切换至 "中华医学电子期刊资源库"
高级检索
中华危重症医学杂志(电子版)

中华危重症医学杂志(电子版) ›› 2020, Vol. 13 ›› Issue (02) : 118 -123. doi: 10.3877/cma.j.issn.1674-6880.2020.02.008

所属专题： 文献；

论著

右美托咪定对甲醛致疼痛小鼠炎症介质释放的干预研究
夏黎1, 林欣1, 孙岩1, 王永芳2,†()   
  1. 1. 215300　江苏苏州，江苏大学附属昆山医院麻醉科
    2. 215300　江苏苏州，江苏大学附属昆山医院重症医学科
  • 收稿日期:2020-02-12 出版日期:2020-04-01
  • 通信作者: 王永芳
  • 基金资助:
    苏州市科技计划项目(SYSD2018022)

Interventional study of dexmedetomidine on inflammatory release in mice with formaldehyde-induced pain

Li Xia1, Xin Lin1, Yan Sun1, Yongfang Wang2,†()   

  1. 1. Department of Anesthesiology, Kunshan Hospital Affiliated to Jiangsu University, Suzhou 215300, China
    2. Department of Intensive Care Unit, Kunshan Hospital Affiliated to Jiangsu University, Suzhou 215300, China
  • Received:2020-02-12 Published:2020-04-01
  • Corresponding author: Yongfang Wang
  • About author:
    Corresponding author: Wang Yongfang, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

夏黎, 林欣, 孙岩, 王永芳. 右美托咪定对甲醛致疼痛小鼠炎症介质释放的干预研究[J]. 中华危重症医学杂志(电子版), 2020, 13(02): 118-123.

Li Xia, Xin Lin, Yan Sun, Yongfang Wang. Interventional study of dexmedetomidine on inflammatory release in mice with formaldehyde-induced pain[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(02): 118-123.

目的

探讨右美托咪定对甲醛致疼痛小鼠炎症介质P物质（SP）、降钙素基因相关肽（CGRP）及血清中肿瘤坏死因子α（TNF-α）、白细胞介素1β（IL-1β）和IL-6的影响。

方法

将40只雄性C57小鼠分成对照组、低剂量组、中剂量组和高剂量组，每组10只。低、中、高剂量组小鼠分别给予腹腔内注射10、20、30 μg/kg右美托咪定，对照组小鼠给予腹腔注射10 mL/kg等渗NaCl溶液。注射后30 min，在异氟烷麻醉下于各组小鼠右足底皮下注射2%甲醛20 μL，记录各组小鼠的舔舐时间。采用免疫荧光染色观察小鼠脊髓和神经节SP和CGRP表达水平，并行酶联免疫吸附测定（ELISA）检测脊髓和神经节上清中SP、CGRP以及血清中TNF-α、IL-1β及IL-6表达水平。

结果

足底注射甲醛后，对照组小鼠的舔舐时间为（12.9 ± 5.0）s，而低、中、高剂量组小鼠的舔舐时间分别为（8.4 ± 3.1）s、（7.9 ± 2.7）s、（7.8 ± 2.5）s。4组小鼠舔舐时间比较，差异有统计学意义（F = 19.472，P = 0.018），且对照组小鼠舔舐时间较低、中、高剂量组小鼠均显著延长（P均< 0.05）。免疫荧光染色结果显示，对照组小鼠脊髓背角和结状神经节处SP表达量较高，可见亮绿色荧光纤维，低、中剂量组SP表达水平较对照组显著降低，高剂量组小鼠SP表达最少；且各组小鼠脊髓背角和结状神经节处CGRP表达均较低，未见明显红色阳性纤维和神经元胞体。ELISA结果显示，对照组、低剂量组、中剂量组和高剂量组小鼠脊髓背角处SP [（43 ± 9）、（33 ± 7）、（31 ± 7）、（20 ± 5）ng/L]、结状神经节处SP [（30 ± 7）、（20 ± 5）、（22 ± 5）、（13 ± 3）ng/L]以及血清中TNF-α [（381 ± 60）、（340 ± 54）、（330 ± 48）、（289 ± 41）ng/L]、IL-1β [（68 ±19）、（55 ± 16）、（52 ± 16）、（41 ± 13）ng/L]和IL-6 [（55 ± 15）、（53 ± 15）、（45 ± 11）、（39 ± 10）ng/L]表达水平比较，差异均有统计学意义（F = 6.527、5.269、35.612、33.843、37.175，P = 0.031、0.022、0.036、0.048、0.029）。进一步两两比较发现，低、中、高剂量组小鼠脊髓背角处SP、结状神经节处SP、血清中TNF-α和IL-1β以及中、高剂量组小鼠血清中IL-6表达水平均较对照组显著降低，且高剂量组较低、中剂量组小鼠脊髓背角处SP、结状神经节处SP以及血清中TNF-α、IL-1β和IL-6表达水平更低（P均< 0.05）。

结论

脊髓背角及结状神经节处的神经肽SP可能参与了疼痛相关的炎症介质释放，而右美托咪定可抑制其表达，同时减轻血清中的炎症因子水平。

关键词: 右美托咪定, 疼痛, 神经肽, 炎症因子
Objective

To investigate the effect of dexmedetomidine on inflammatory mediators of substance P (SP), calcitonin gene related peptide (CGRP), serum tumor necrosis factor-alpha (TNF-α), interleukin-1beta (IL-1β), and IL-6 in mice with formaldehyde-induced pain.

Methods

Forty male C57 mice were divided into a control group, a low dose group, a medium dose group and a high dose group, 10 in each group. Mice in the low, medium and high dose groups were given intraperitoneal injection of 10, 20, and 30 μg/kg dexmedetomidine respectively, while mice in the control group were given intraperitoneal injection of 10 mL/kg isosmotic NaCl solution. Thirty minutes later, 20 μL of 2% formaldehyde was subcutaneously injected into the right foot of mice under isoflurane anesthesia, and the licking time was recorded in each group. The expression levels of SP and CGRP in the spinal cord and ganglion were observed by immunofluorescence staining. The expression levels of SP, CGRP in the spinal cord and ganglion supernatant and TNF-α, IL-1β, IL-6 in serum were determined by enzyme-linked immunosorbent assay (ELISA).

Results

After the plantar injection of formaldehyde, the licking time was (12.9 ± 5.0) s in the control group, (8.4 ± 3.1) s in the low dose group, (7.9 ± 2.7) s in the medium dose group, and (7.8 ± 2.5) s in the high dose group. It was significantly different among these four groups (F = 19.472, P = 0.018), and mice had significantly prolonged licking time in the control group than in the other three groups (all P < 0.05). Immunofluorescence staining showed that the SP expression level at the dorsal horn of spinal cord and nodular ganglia was higher in the control group than in the other three groups, with bright green fluorescent fibers, and that it was minimal in the high dose group. In the meantime, the CGRP expression level at the dorsal horn of spinal cord and nodular ganglia was low in each group, and no red positive fibers and neuronal cell bodies were obviously found. ELISA showed that the expression levels of SP at the dorsal horn of spinal cord [(43 ± 9), (33 ± 7), (31 ± 7), (20 ± 5) ng/L], SP at nodular ganglia [(30 ± 7), (20 ± 5), (22 ± 5), (13 ± 3) ng/L], TNF-α [(381 ± 60), (340 ± 54), (330 ± 48), (289 ± 41) ng/L], IL-1β [(68 ± 19), (55 ± 16), (52 ± 16), (41 ± 13) ng/L], and IL-6 [(55 ± 15), (53 ± 15), (45 ± 11), (39 ± 10) ng/L] were statistically different among the control group, low dose group, medium dose group and high dose group (F = 6.527, 5.269, 35.612, 33.843, 37.175; P = 0.031, 0.022, 0.036, 0.048, 0.029). In further pairwise comparison, the expression levels of SP at the dorsal horn of spinal cord and nodular ganglia, TNF-α and IL-1β in the low, medium and high dose groups, and IL-6 in the medium and high dose groups were significantly lower than those in the control group, and those were lowest in the high dose group (all P < 0.05).

Conclusion

The neuropeptide SP at the dorsal horn of spinal cord and nodular ganglia may be involved in the release of pain-related inflammatory mediators, while dexmedetomidine inhibits their expressions and reduces levels of inflammatory factors in serum.

Key words: Dexmedetomidine, Pain, Neuropeptide, Inflammatory mediator
图1 4组小鼠脊髓背角处SP和CGRP免疫荧光染色结果
表1 4组小鼠脊髓背角处SP和CGRP表达水平的比较（ng/L，±s）
组别 只数 SP CGRP
对照组 10 43 ± 9 26 ± 8
低剂量组 10 33 ± 7a 29 ± 9
中剂量组 10 31 ± 7a 23 ± 8
高剂量组 10 20 ± 5abc 25 ± 8
F值 ? 6.527 30.893
P值 ? 0.031 0.159
图2 4组小鼠结状神经节处SP和CGRP免疫荧光染色结果
表2 4组小鼠结状神经节处SP和CGRP表达水平的比较（ng/L，±s）
组别 只数 SP CGRP
对照组 10 30 ± 7 19 ± 7
低剂量组 10 20 ± 5a 20 ± 6
中剂量组 10 22 ± 5a 16 ± 6
高剂量组 10 13 ± 3abc 17 ± 7
F值 ? 5.269 29.822
P值 ? 0.022 0.198
表3 4组小鼠血清中TNF-α、IL-1β及IL-6表达水平的比较（ng/L，±s）
组别 只数 TNF-α IL-1β IL-6
对照组 10 381 ± 60 68 ± 19 55 ± 15
低剂量组 10 340 ± 54a 55 ± 16a 53 ± 15
中剂量组 10 330 ± 48a 52 ± 16a 45 ± 11ab
高剂量组 10 289 ± 41abc 41 ± 13abc 39 ± 10abc
F值 ? 35.612 33.843 37.175
P值 ? 0.036 0.048 0.029
[1]
Inada T, Shirane A, Hamano N, et al. Effect of subhypnotic doses of dexmedetomidine on antitumor immunity in mice[J]. Immunopharmacol Immunotoxicol, 2005, 27 (3): 357-369.
[2]
Eippert F, Tracey I. Pain and the PAG: learning from painful mistakes[J]. Nat Neurosci, 2014, 17 (11): 1438-1439.
[3]
Rodríguez-Munoz M, Sánchez-Blázquez P, Vicente-Sánchez A, et al. The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control[J]. Neuropsychopharmacology, 2012, 37 (2): 338-349.
[4]
Tortorici V, Aponte Y, Acevedo H, et al. Tolerance to non-opioid analgesics in PAG involves unresponsiveness of medullary pain-modulating neurons in male rats[J]. Eur J Neurosci, 2009, 29 (6): 1188-1196.
[5]
Wu X, Li HD, Li XC, et al. Effects of intra-hippocampal injection of interleukin-2 on pain threshold and formaldehyde-induced substance P-like immunoreactivity in periaqueductal gray and spinal cord[J]. Zhongguo Yao Li Xue Bao, 1999, 20 (9): 839-843.
[6]
Wan FP, Bai Y, Kou ZZ, et al. Endomorphin-2 inhibition of substance P signaling within lamina I of the spinal cord is impaired in diabetic neuropathic pain rats[J]. Front Mol Neurosci, 2017 (9): 167.
[7]
Chen YW, Tzeng JI, Lin MF, et al. Forced treadmill running suppresses postincisional pain and inhibits upregulation of substance P and cytokines in rat dorsal root ganglion[J]. J Pain, 2014, 15 (8): 827-834.
[8]
Pasin L, Greco T, Feltracco P, et al. Dexmedetomidine as a sedative agent in critically ill patients: a meta-analysis of randomized controlled trials[J]. PLoS One, 2013, 8 (12): e82913.
[9]
Oschman A, McCabe T, Kuhn RJ. Dexmedetomidine for opioid and benzodiazepine withdrawal in pediatric patients[J]. Am J Health Syst Pharm, 2011, 68 (13): 1233-1238.
[10]
马燕，拜合提尼沙·吐尔地，于湘友，等.不同剂量右美托咪定对脓毒症大鼠微循环的影响[J/CD].中华危重症医学杂志（电子版），2018，11（1）：11-16.
[11]
Yang W, Kong LS, Zhu XX, et al. Effect of dexmedetomidine on postoperative cognitive dysfunction and inflammation in patients after general anaesthesia: a PRISMA-compliant systematic review and meta-analysis[J]. Medicine (Baltimore), 2019, 98 (18): e15383.
[12]
Bao Y, Zhu Y, He G, et al. Dexmedetomidine attenuates neuroinflammation in LPS-stimulated BV2 microglia cells through upregulation of miR-340[J]. Drug Des Devel Ther, 2019 (13): 3465-3475.
[13]
Wu JR, Chen H, Yao YY, et al. Local injection to sciatic nerve of dexmedetomidine reduces pain behaviors, SGCs activation, NGF expression and sympathetic sprouting in CCI rats[J]. Brain Res Bull, 2017 (132): 118-128.
[14]
Grosu I, Lavand'homme P. Use of dexmedetomidine for pain control[J]. F1000 Med Rep, 2010 (2): 90.
[15]
杨颖聪，夏中元，孟庆涛，等.右美托咪定对神经病理性疼痛的作用及其机制[J].医学研究杂志，2018，47（7）：78-83.
[16]
Zhong JM, Lu YC, Zhang J. Dexmedetomidine reduces diabetic neuropathy pain in rats through the Wnt 10a/β-catenin signaling pathway[J]. Biomed Res Int, 2018: 9043628.
[17]
Xun S, Zheng R. Dexmedetomidine alleviates neuropathic pain by regulating JAK/STAT pathway in rats[J]. J Cell Biochem, 2020, 121 (3): 2277-2283.
[18]
Sun Z, Lin Y, Li Y, et al. The effect of dexmedetomidine on inflammatory inhibition and microglial polarization in BV-2 cells[J]. Neurol Res, 2018, 40 (10): 838-846.
[19]
Chen N, Chen X, Xie J, et al. Dexmedetomidine protects aged rats from postoperative cognitive dysfunction by alleviating hippocampal inflammation[J]. Mol Med Rep, 2019, 20 (3): 2119-2126.
[1] 刘嘉嘉, 王承华, 陈绪娇, 刘瑗玲, 王善钰, 屈海花, 张莉. 经阴道子宫-输卵管实时三维超声造影中患者疼痛发生情况及其影响因素分析[J]. 中华医学超声杂志（电子版）, 2023, 20(09): 959-965.
[2] 董红华, 郭艮春, 江磊, 吴雪飞, 马飞翔, 李海凤. 骨科康复一体化模式在踝关节骨折快速康复中的应用[J]. 中华关节外科杂志(电子版), 2023, 17(06): 802-807.
[3] 利洪艺, 杨浪, 温国洪, 关鸿, 茹江英, 王湘江. 全膝股骨假体矢状面位置与术后膝前痛及功能的关系[J]. 中华关节外科杂志(电子版), 2023, 17(04): 479-484.
[4] 徐娟, 孙汝贤, 赵东亚, 张清艳, 金兆辰, 蔡燕. 右美托咪定序贯镇静模式对中深度镇静的机械通气患者预后和谵妄的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(05): 363-369.
[5] 吴畏, 吴永哲, 李宗倍, 崔宏力, 李华志, 许臣. 轻质大网孔补片腹腔镜下疝修补术治疗老年腹股沟疝的疗效及炎症因子的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 70-73.
[6] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[7] 王敏, 蒋家斌, 李茂新. 预警宣教联合个性化疼痛管理对腹股沟疝手术患者的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 764-767.
[8] 王可, 范彬, 李多富, 刘奎. 两种疝囊残端处理方法在经腹腹膜前腹股沟疝修补术中的疗效比较[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 692-696.
[9] 夏松, 姚嗣会, 汪勇刚. 经腹腹膜前与疝环充填式疝修补术治疗腹股沟疝的对照研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 702-705.
[10] 刘骏, 朱霁, 殷骏. 右美托咪定对腹股沟疝手术麻醉效果及安全性的影响[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 570-573.
[11] 周晓艳, 王志钢, 周冬喜. 超声引导下腹横肌平面阻滞在腹腔镜腹股沟疝手术中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(05): 579-583.
[12] 关明函, 薛志强. 右美托咪定改善大鼠脑缺血再灌注后脑损伤的研究[J]. 中华神经创伤外科电子杂志, 2023, 09(05): 270-276.
[13] 付强, 秦丽媛, 李全波. 神经病理性疼痛患者血清miR-15a水平及意义分析[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 293-298.
[14] 屈霄, 王靓, 陆萍, 何斌, 孙敏. 外周血炎症因子及肠道菌群特征与活动性溃疡性结肠炎患者病情的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 466-470.
[15] 黄泽辉, 梁杰贤, 曾伟. 右美托咪定联合艾司氯胺酮在小儿无痛胃镜检查中的应用研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 510-513.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号